CXCR4 overexpression: an indicator of poor survival and predictor of response to immunotherapy in patients with metastatic colorectal cancer | Caris Life Sciences
Home / Research / Publications / CXCR4 overexpression: an indicator of poor survival and predictor of response to immunotherapy in patients with metastatic colorectal cancer

Publications

CXCR4 overexpression: an indicator of poor survival and predictor of response to immunotherapy in patients with metastatic colorectal cancer

Key Finding:

Colorectal cancer patients with high tumoral CXCR4 expression had improved survival when treated with pembrolizumab. 

Download Publication
Learn More
Name(Required)